| Datum | Zeit | Quelle | Überschrift | Symbol | Firma |
| 14/02/2018 | 23h54 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:OCRX | Ocera Therapeutics, Inc. (MM) |
| 14/02/2018 | 20h53 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:OCRX | Ocera Therapeutics, Inc. (MM) |
| 21/12/2017 | 22h26 | Edgar (US Regulatory) | Termination of Registration of a Class of Security Under Section 12(b) (15-12b) | NASDAQ:OCRX | Ocera Therapeutics, Inc. (MM) |
| 21/12/2017 | 12h04 | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (sc 13d/a) | NASDAQ:OCRX | Ocera Therapeutics, Inc. (MM) |
| 14/12/2017 | 18h08 | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (sc 13d/a) | NASDAQ:OCRX | Ocera Therapeutics, Inc. (MM) |
| 14/12/2017 | 12h01 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:OCRX | Ocera Therapeutics, Inc. (MM) |
| 14/12/2017 | 12h01 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:OCRX | Ocera Therapeutics, Inc. (MM) |
| 14/12/2017 | 12h01 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:OCRX | Ocera Therapeutics, Inc. (MM) |
| 13/12/2017 | 23h00 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OCRX | Ocera Therapeutics, Inc. (MM) |
| 13/12/2017 | 22h54 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OCRX | Ocera Therapeutics, Inc. (MM) |
| 13/12/2017 | 22h44 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OCRX | Ocera Therapeutics, Inc. (MM) |
| 13/12/2017 | 22h40 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OCRX | Ocera Therapeutics, Inc. (MM) |
| 13/12/2017 | 22h33 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OCRX | Ocera Therapeutics, Inc. (MM) |
| 11/12/2017 | 21h26 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OCRX | Ocera Therapeutics, Inc. (MM) |
| 11/12/2017 | 21h26 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OCRX | Ocera Therapeutics, Inc. (MM) |
| 11/12/2017 | 21h26 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OCRX | Ocera Therapeutics, Inc. (MM) |
| 11/12/2017 | 21h25 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OCRX | Ocera Therapeutics, Inc. (MM) |
| 11/12/2017 | 21h24 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OCRX | Ocera Therapeutics, Inc. (MM) |
| 11/12/2017 | 21h21 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OCRX | Ocera Therapeutics, Inc. (MM) |
| 11/12/2017 | 21h21 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OCRX | Ocera Therapeutics, Inc. (MM) |
| 11/12/2017 | 21h20 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OCRX | Ocera Therapeutics, Inc. (MM) |
| 11/12/2017 | 21h20 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OCRX | Ocera Therapeutics, Inc. (MM) |
| 11/12/2017 | 16h26 | Edgar (US Regulatory) | Post-effective Amendment to Registration Statement (pos Am) | NASDAQ:OCRX | Ocera Therapeutics, Inc. (MM) |
| 11/12/2017 | 16h26 | Edgar (US Regulatory) | Post-effective Amendment to Registration Statement (pos Am) | NASDAQ:OCRX | Ocera Therapeutics, Inc. (MM) |
| 11/12/2017 | 16h23 | Edgar (US Regulatory) | Post-effective Amendment to Registration Statement (pos Am) | NASDAQ:OCRX | Ocera Therapeutics, Inc. (MM) |
| 11/12/2017 | 16h22 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:OCRX | Ocera Therapeutics, Inc. (MM) |
| 11/12/2017 | 16h19 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:OCRX | Ocera Therapeutics, Inc. (MM) |
| 11/12/2017 | 16h18 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:OCRX | Ocera Therapeutics, Inc. (MM) |
| 11/12/2017 | 16h16 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:OCRX | Ocera Therapeutics, Inc. (MM) |
| 11/12/2017 | 16h13 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:OCRX | Ocera Therapeutics, Inc. (MM) |